STUDY DESIGN OPEN, PARALLEL STUDY
Dosage/Product 0.5% formulation active/placebo, applied twice daily
No. of Subjects 21 Subjects
Gender 9 Males, 12 females
Age 18-28 years, avergage age 21
Duration 8 weeks
Endpoints
  • Dermalogical Assessment (Acne grading and clinical grading)
  • Instrumental Assessment (using Sebumeter)
  • Subject Self Assessment
  • Safety
Results
  • Significantly improved acne-prone skin (p<0.05) after 8 weeks
  • Reduction of sebum by 21%, Acnaed® may be useful for general facial maintenance (face cream, lotion, masks, toner etc)
  • No adverse skin reaction, safe

PRE-CLINICAL STUDIES ON ACNAED®

SRAIN AVCO MMC90 RESULT
C.albicans 0.31
S.aureus 0.31
E.coli 1.56
T.rubrum 10
P.ovale 1
H.pylori 0.03
P.acne (causing Acne vulgaris) 0.01
S.thyphirium 10